A 2023 study finds adults with anxiety report better self-reported sleep after cannabis days than alcohol days, but results are exploratory and not conclusive.
Massachusetts teen cannabis use did not rise after adult-use legalization; a 2023 study shows shifting peer-perception patterns, hinting at targeted prevention.
Delta-8 may feel milder than Delta-9, but safety and labeling remain uncertain—read why testing, dose, and regulation shape your risk.
Track medical cannabis use safely with a practical journal: log dose, timing, symptoms and side effects to spot patterns and improve talks with your clinician.
Real-world data suggest inhaled cannabis may provide short-term relief for headaches and migraines, with symptom reductions, though causality remains unproven.
Small trial finds purified CBD reduced acute toothache vs placebo, hinting at a potential nonopioid option for short-term dental pain, not yet proven.
A 2023 survey finds many cannabis users report better sleep and morning relief vs rx/OTC sleep aids, but researchers urge caution and more studies.
What’s driving the shift in teen cannabis use? U.S. high school seniors increasingly vape and eat cannabis from 2015–2018, even as smoking falls.
CBD and sleep: dose may matter more than you think—exploring mixed evidence, no proven insomnia dose, and what to consider before using CBD for rest.
A 2023 study links recreational cannabis legalization to fewer documented cannabis use disorder diagnoses in certain ER visits, but causation isn't proven.